PAPER Poulsen K, Bahl JM, Simonsen AH, Hasselbalch SG, Heegaard NH
SEARCH RESULTS
329938 RESULTS
PAPER Rist PM, Capistrant BD, Wu Q, Marden JR, Glymour MM
Dementia and dependence: do modifiable risk factors delay disability?
Neurology. 2014 Apr 29;82(17):1543-50. Epub 2014 Mar 28 PubMed: 24682970PAPER Kotagal V, Albin RL, Müller ML, Koeppe RA, Frey KA, Bohnen NI
Modifiable cardiovascular risk factors and axial motor impairments in Parkinson disease.
Neurology. 2014 Apr 29;82(17):1514-20. Epub 2014 Mar 28 PubMed: 24682965PAPER Reddy PH
Increased mitochondrial fission and neuronal dysfunction in Huntington's disease: implications for molecular inhibitors of excessive mitochondrial fission.
Drug Discov Today. 2014 Jul;19(7):951-5. Epub 2014 Mar 28 PubMed: 24681059PAPER Hall JM, Shine JM, Walton CC, Gilat M, Kamsma YP, Naismith SL, Lewis SJ
Early phenotypic differences between Parkinson's disease patients with and without freezing of gait.
Parkinsonism Relat Disord. 2014 Jun;20(6):604-7. Epub 2014 Mar 12 PubMed: 24679901PAPER de Lau LM, Verbaan D, Marinus J, van Hilten JJ
Survival in Parkinson's disease. Relation with motor and non-motor features.
Parkinsonism Relat Disord. 2014 Jun;20(6):613-6. Epub 2014 Mar 12 PubMed: 24679900PAPER Katayama S, Imai R, Sugiyama H, Nakamura S
Oral administration of soy peptides suppresses cognitive decline by induction of neurotrophic factors in SAMP8 mice.
J Agric Food Chem. 2014 Apr 23;62(16):3563-9. Epub 2014 Apr 8 PubMed: 24678753PAPER Sollberger M, Rosen HJ, Shany-Ur T, Ullah J, Stanley CM, Laluz V, Weiner MW, Wilson SM, Miller BL, Rankin KP
Neural substrates of socioemotional self-awareness in neurodegenerative disease.
Brain Behav. 2014 Mar;4(2):201-14. Epub 2014 Jan 13 PubMed: 24683513PAPER Zeng L, Tallaksen-Greene SJ, Wang B, Albin RL, Paulson HL
The de-ubiquitinating enzyme ataxin-3 does not modulate disease progression in a knock-in mouse model of Huntington disease.
J Huntingtons Dis. 2013 Jun 18;2(1):201-215. PubMed: 24683430PAPER Li DW, Liu ZQ, Chen W, Yao M, Li GR
Association of glycogen synthase kinase-3β with Parkinson's disease (review).
Mol Med Rep. 2014 Jun;9(6):2043-50. Epub 2014 Mar 28 PubMed: 24681994PAPER O'Flanagan CH, Morais VA, Wurst W, De Strooper B, O'Neill C
The Parkinson's gene PINK1 regulates cell cycle progression and promotes cancer-associated phenotypes.
Oncogene. 2014 Mar 31;0 PubMed: 24681957PAPER Kondadi AK, Wang S, Montagner S, Kladt N, Korwitz A, Martinelli P, Herholz D, Baker MJ, Schauss AC, Langer T, Rugarli EI
Loss of the m-AAA protease subunit AFG₃L₂ causes mitochondrial transport defects and tau hyperphosphorylation.
EMBO J. 2014 May 2;33(9):1011-26. Epub 2014 Mar 28 PubMed: 24681487PAPER Kachroo A, Schwarzschild MA
Allopurinol reduces levels of urate and dopamine but not dopaminergic neurons in a dual pesticide model of Parkinson's disease.
Brain Res. 2014 May 14;1563:103-9. Epub 2014 Mar 26 PubMed: 24680743PAPER Tsivgoulis G, Bonakis A, Papathanasiou MA, Chondrogianni M, Papageorgiou SG, Voumvourakis K, Stefanis L
Magnetic resonance imaging reveals Creutzfeldt-Jakob disease in a patient with apparent dementia with Lewy bodies.
J Neurol Sci. 2014 May 15;340(1-2):130-2. Epub 2014 Mar 11 PubMed: 24680564PAPER Mackin RS, Nelson JC, Delucchi KL, Raue PJ, Satre DD, Kiosses DN, Alexopoulos GS, Arean PA
Association of Age at Depression Onset with Cognitive Functioning in Individuals with Late-Life Depression and Executive Dysfunction.
Am J Geriatr Psychiatry. 2014 Feb 26; PubMed: 24680502Current Filters
No filters selected